Articles

Page 106 of 108

Two molecular cytogenetic views of breast cancer

Authors: J Gray, K Chin, C Collins, P Yaswin, G Nonet, D Kowbel, W-L Kuo, E Garcia, C Ortiz de Solorzano, D Knowles, S Lockett, M Bissell, V Weaver, D Pinkel, D Albertson, A-L Børresen-Dale…

Citation: Breast Cancer Research 2000 2(Suppl 1):S.35

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Clinical trials in breast cancer; do we have the right approaches?

Authors: PE Lønning

Citation: Breast Cancer Research 2000 2(Suppl 1):S.33

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Hypoxia and tumour angiogenesis involved in breast cancer progression and targets for therapy

Authors: AL Harris

Citation: Breast Cancer Research 2000 2(Suppl 1):S.28

Content type: Speaker presentations Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
p53 action in apoptosis and senescence

Authors: SW Lowe, CA Schmitt, G Ferbeyre, AW Lin, E de Stanchina and M Soengas

Citation: Breast Cancer Research 2000 2(Suppl 1):S.22

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
p53-mediated apoptosis and genomic instability syndromes

Authors: EA Spillare, XW Wang, SP Linke, A Robles and CC Harris

Citation: Breast Cancer Research 2000 2(Suppl 1):S.20

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Drug discovery in the p53 pathway

Authors: DP Lane, C Midgley, A Sparks, C Blattner, C Binden and S Laine

Citation: Breast Cancer Research 2000 2(Suppl 1):S.18

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Characterisation of micrometastatic tumor cells

Authors: K Pantel

Citation: Breast Cancer Research 2000 2(Suppl 1):S.16

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Clinical translation of progress in molecular endocrinology

Authors: M Dowsett

Citation: Breast Cancer Research 2000 2(Suppl 1):S.12

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Estrogen receptors α and β in the rodent mammary gland

Authors: S Saji, EV Jensen, S Nilsson, T Rylander, M Warner and J-Å Gustafsson

Citation: Breast Cancer Research 2000 2(Suppl 1):S.11

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Comparative genomic hybridisation analysis of myoepithelial carcinoma of the breast

Authors: C Jones, MP Foschini, R Chaggar, Y-J Lu, D Wells, JM Shipley, V Eusebi and SR Lakhani

Citation: Breast Cancer Research 2000 2(Suppl 1):P8.06

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Relation of gene expression-based tumor subclasses to clinical phenotypes

Authors: T Sørlie, CM Perou, PE Lønning, PO Brown, D Botstein and A-L Børresen-Dale

Citation: Breast Cancer Research 2000 2(Suppl 1):P8.11

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Screening for BRCA1 gene mutations by capillary electrophoretic REF-SSCP

Authors: P Kringen, HG Eiken, JC Pedersen, S Egedal, K Berg, KM Tveit and TI Andersen

Citation: Breast Cancer Research 2000 2(Suppl 1):P8.04

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
REAL Real-Time!

Authors: F Boeckman, L Tan and K Hamby

Citation: Breast Cancer Research 2000 2(Suppl 1):P8.02

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
The role of coactivators in oestrogen action

Authors: M Brown and JF de Mora

Citation: Breast Cancer Research 2000 2(Suppl 1):S.08

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Identification of two novel breast cancer associated genes by the differential display method

Authors: N Maass, K Nagasaki, VR Jacobs and W Jonat

Citation: Breast Cancer Research 2000 2(Suppl 1):P8.08

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Cytokeratin and mammaglobin as tumor markers in patients with high risk breast cancer

Authors: PF Ferrucci, C Rabascio, C Corsini, F Tealdo, M Paolucci, F Bertolini, H El Taani and G Martinelli

Citation: Breast Cancer Research 2000 2(Suppl 1):P7.05

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
AKT-1 and BCL-2 co-expression in breast cancer patients correlates with better survival

Authors: G Pérez-Tenorio and O Stål

Citation: Breast Cancer Research 2000 2(Suppl 1):P7.02

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Ribozymes targeting the tumor suppressor BRCA1 lead to increased chemosensitivity to cisplatin and etoposide and chemoresistance to microtubule-interfering agents in HBL100 breast cancer cell line

Authors: S Lafarge, M Ferrara and YJ Bignon

Citation: Breast Cancer Research 2000 2(Suppl 1):P7.04

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation

Authors: J DiRenzo, R Rivera-Gonzalez and M Brown

Citation: Breast Cancer Research 2000 2(Suppl 1):P6.03

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Setting up an efficient and reliable screening method for novel c-Jun N-terminal kinase substrates

Authors: T Kallunki, C Holmberg, M Lerdrup-Hansen, T Herdegen, A Aronheim and M Jäättelä

Citation: Breast Cancer Research 2000 2(Suppl 1):P5.05

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
The pathology of inherited breast tumours

Authors: M Stratton

Citation: Breast Cancer Research 2000 2(Suppl 1):S.05

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
p16^INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

Authors: S Geisler, B Smith-Sørensen, D Betticher, IK Bukholm, LA Akslen, A Kappeler, M Gugger, PE Lønning and A-L Børresen-Dale

Citation: Breast Cancer Research 2000 2(Suppl 1):P5.01

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Estrogen-dependent c-jun upregulation may control cyclin D1 expression

Authors: MD Planas-Silva, J Liu Donaher and RA Weinberg

Citation: Breast Cancer Research 2000 2(Suppl 1):P5.03

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Studies of TP53 haplotypes in relation to LOH and TP53 mutations in breast cancer patients

Authors: A Langerød, TI Andersen, I Bukholm and A-L Børresen Dale

Citation: Breast Cancer Research 2000 2(Suppl 1):P4.06

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Analysis of Fhit expression in stages of breast cancer progression

Authors: M Campiglio, G Somenzi, P Aiello, F Wärnberg, L Holmberg, CM Croce and S Menard

Citation: Breast Cancer Research 2000 2(Suppl 1):P4.12

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
The GSTT1 genotype is associated with p53 mutation status of breast cancer tumours

Authors: K Gudmundsdóttir, L Tryggvadóttir and JE Eyfjörd

Citation: Breast Cancer Research 2000 2(Suppl 1):P4.05

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
BRCA2 interacting proteins

Authors: H Vidarsson, E Mikaelsdottir, JE Eyfjörd, H Ögmundsdóttir, T Rafnar and S Valgeirsdóttir

Citation: Breast Cancer Research 2000 2(Suppl 1):P4.02

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Expression of variant forms of the MUC1 gene correlates with the invasiveness of breast cancer cells

Authors: R Zeillinger, B Schmid, D Tong, B Fasching, I Schiebl, M Stimpfl, A Obermair and S Leodolter

Citation: Breast Cancer Research 2000 2(Suppl 1):P4.16

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Expression of Akt kinases related to ErbB2 and results of adjuvant therapy of breast cancer

Authors: O Stal, L Akerberg, B Nordenskjold, B Olsson, LE Rutqvist and L Skoog

Citation: Breast Cancer Research 2000 2(Suppl 1):P3.04

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
HER-2 activation and TP53 inactivation as predictors of survival in breast cancer

Authors: TI Andersen, E Skovlund, IK Bukholm, U Jacobsen, R Kåresen, B Erikstein, J Nesland and A-L Børresen-Dale

Citation: Breast Cancer Research 2000 2(Suppl 1):P3.07

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Activation of the Her2/neu receptor leads to antiestrogen resistance, but acquired resistance is not caused by altered ErbB expression and activation

Authors: SS Larsen and AE Lykkesfeldt

Citation: Breast Cancer Research 2000 2(Suppl 1):P3.03

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Phosphorylation of human progesterone receptors by MAPKs mediates transcriptional synergy between progestins and MEKK1 in human breast cancer cells

Authors: CA Lange, T Shen and KB Horwitz

Citation: Breast Cancer Research 2000 2(Suppl 1):P2.06

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Germline mutations of BRCA1-associated RING domain (BARD1) gene in breast and/or ovarian families negative for BRCA1 and 2 alterations

Authors: C Ghimenti, E Sensi, D Iandolo, G Cipollini, S Ricci, PF Conte, G Bevilacqua and MA Caligo

Citation: Breast Cancer Research 2000 2(Suppl 1):P1.15

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Constitutional alterations of 9p23-24 in independent BRCA2 breast cancer families

Authors: M Schwab, L Savelyeva, A Claas, H An and S Brouwers

Citation: Breast Cancer Research 2000 2(Suppl 1):P1.13

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
The importance of breast cancer research from a patient's view: the voices and visions of advocates

Authors: S Leigh

Citation: Breast Cancer Research 2000 2(Suppl 1):S.01

Content type: Oral presentation Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Germline TP53mutations in Finnish breast cancer patients

Authors: K Rapakko, M Allinen, K Syrjäkoski, P Vahteristo, P Huusko, K Vähäkangas, H Eerola, T Kainu, O-P Kallioniemi, H Nevanlinna and R Winqvist

Citation: Breast Cancer Research 2000 2(Suppl 1):P1.09

Content type: Meeting abstract Published on: 12 March 2000

This article is part of a Supplement: Volume 2 Supplement 1
- View Full Text
- View PDF
Altered expression of estrogen receptor-α variant messenger RNAs between adjacent normal breast and breast tumor tissues

Using semiquantitative reverse transcription-polymerase chain reaction assays, we investigated the expression of variant messenger RNAs relative to wild-type estrogen receptor (ER)-α messenger RNA in normal br...

Authors: Etienne Leygue, Helmut Dotzlaw, Peter H Watson and Leigh C Murphy

Citation: Breast Cancer Research 2000 2:64

Content type: Research article Published on: 1 February 2000
- View Full Text
- View PDF
Smoking and high-risk mammographic parenchymal patterns: a case-control study

Current smoking was strongly and inversely associated with high-risk patterns, after adjustment for concomitant risk factors. Relative to never smokers, current smokers were significantly less likely to have a...

Authors: Evis Sala, Ruth Warren, Jenny McCann, Stephen Duffy, Robert Luben and Nicholas Day

Citation: Breast Cancer Research 2000 2:59

Content type: Research article Published on: 1 February 2000
- View Full Text
- View PDF
Gene therapy for carcinoma of the breast: Genetic ablation strategies

The gene therapy strategy of mutation compensation is designed to rectify the molecular lesions that are etiologic for neoplastic transformation. For dominant oncogenes, such approaches involve the functional ...

Authors: David T Curiel

Citation: Breast Cancer Research 2000 2:45

Content type: Review Published on: 1 February 2000
- View Full Text
- View PDF
Gene therapy for carcinoma of the breast: Therapeutic genetic correction strategies

Gene therapy is a therapeutic approach that is designed to correct specific molecular defects that contribute to the cause or progression of cancer. Genes that are mutated or deleted in cancers include the can...

Authors: Patrice S Obermiller, David L Tait and Jeffrey T Holt

Citation: Breast Cancer Research 2000 2:28

Content type: Review Published on: 1 February 2000
- View Full Text
- View PDF
Gene therapy for carcinoma of the breast: Genetic toxins

Gene therapy was initially envisaged as a potential treatment for genetically inherited, monogenic disorders. The applications of gene therapy have now become wider, however, and include cardiovascular disease...

Authors: Georges Vassaux and Nick R Lemoine

Citation: Breast Cancer Research 2000 2:22

Content type: Review Published on: 1 February 2000
- View Full Text
- View PDF
Gene therapy for carcinoma of the breast: Genetic immunotherapy

Advances in gene transfer technology have greatly expanded the opportunities for developing immunotherapy strategies for breast carcinoma. Genetic immunotherapy approaches include the transfer of genes encodin...

Authors: Theresa V Strong

Citation: Breast Cancer Research 2000 2:15

Content type: Review Published on: 1 February 2000
- View Full Text
- View PDF
Beyond the genome to tissue proteomics

Authors: Lance A Liotta and Emanuel F Petricoin

Citation: Breast Cancer Research 2000 2:13

Content type: Commentary Published on: 1 February 2000
- View Full Text
- View PDF
Breast cancer prevention

Authors: Trevor J Powles

Citation: Breast Cancer Research 2000 2:10

Content type: Commentary Published on: 1 February 2000
- View Full Text
- View PDF
Microarray foray

Authors: Robert J Coffey and David Threadgill

Citation: Breast Cancer Research 2000 2:8

Content type: Commentary Published on: 1 February 2000
- View Full Text
- View PDF
Modeling Mammary Cancer in Mice Conference, Jackson Laboratory, Bar Harbor, Maine, 5-8 October, 1999

Authors: Kristen L Murphy, Sandra L Grimm and Jeffrey M Rosen

Citation: Breast Cancer Research 2000 2:E003

Content type: Meeting report Published on: 1 February 2000
- View Full Text
- View PDF
Mouse models for breast cancer

Authors: Lothar Hennighausen

Citation: Breast Cancer Research 2000 2:2

Content type: Commentary Published on: 1 February 2000
- View Full Text
- View PDF
6th Nottingham International Breast Cancer Conference (22-24 September 1999)

Authors: Richard De Boer

Citation: Breast Cancer Research 2000 2:E002

Content type: Meeting report Published on: 1 February 2000
- View Full Text
- View PDF
International Conference on the Biology of the Mammary Gland. Tours, France (16-18 September 1999)

Authors: Roger A Clegg

Citation: Breast Cancer Research 2000 2:E001

Content type: Meeting report Published on: 1 February 2000
- View Full Text
- View PDF
Breast Cancer Research non-peer-review research depository

Authors:

Citation: Breast Cancer Research 2000 2:1

Content type: Announcement Published on: 1 February 2000
- View Full Text
- View PDF

How was your experience today?

Rating Please select one rating

Awful

Bad

Good

Great

Thank you for your feedback.

Tell us why (opens in a new tab)

Articles

Follow

Annual Journal Metrics

Breast Cancer Research

Contact us